<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02571803</url>
  </required_header>
  <id_info>
    <org_study_id>2.15/III/15</org_study_id>
    <nct_id>NCT02571803</nct_id>
  </id_info>
  <brief_title>Dietary Intervention to Stop COronary Atherosclerosis in Computed Tomography</brief_title>
  <acronym>DISCO-CT</acronym>
  <official_title>The Effect of Strict Dietary Intervention on Atherosclerotic Lesions in Patients Diagnosed With Coronary Artery Disease, Assessed by Coronary Computed Tomography Angiography (CCTA).</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institute of Cardiology, Warsaw, Poland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Institute of Cardiology, Warsaw, Poland</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to determine, wheather strict dietary intervention with the use of&#xD;
      the DASH diet atop of optimal medical treatment reduces previously diagnosed coronary&#xD;
      atherosclerotic lesions assessed witch coronary computed tomography.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A total of 180 patients with coronary atheroslerotc lesions confirmed in coronary computed&#xD;
      tomography (CCT) will be analyzed in a 12-month observation time. Patients will be randomized&#xD;
      to two groups in a 1:1 fashion. 1 - optimal medical treatment, 2 - strict dietary&#xD;
      intervention with implementation of the DASH diet atop of optimal medical treatment. CCT&#xD;
      scans will be performed at screening and at 12 months after randomization. Computed&#xD;
      tomography imaging data describing atheroslerotic lesions will be assessed.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>October 2015</start_date>
  <completion_date type="Anticipated">October 2018</completion_date>
  <primary_completion_date type="Anticipated">June 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percent Of Patheroma Volume (PAV)</measure>
    <time_frame>12 months</time_frame>
    <description>Reduction of percent atheroma volume (PAV) measured between baseline and follow-up CT scans.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pericardial Fat Distribution</measure>
    <time_frame>12 months</time_frame>
    <description>Change in pericardial fat distribution between baseline and follow-up CT scans.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">180</enrollment>
  <condition>Coronary Artery Disease</condition>
  <arm_group>
    <arm_group_label>Dietary And Lifestyle Counseling</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients receiving strict dietary counseling (implementation of the DASH diet) and lifestyle changes support atop of optimal medical treatment as per 2013 ESC guidelines on the management of stable coronary artery disease.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Optimal Medical Treatment</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients receiving optimal medical treatment as per 2013 ESC guidelines on the management of stable coronary artery disease.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Dietary And Lifestyle Counseling</intervention_name>
    <description>The DASH (Dietary Approaches to Stop Hypertension) diet is a dietary pattern of proven effect on arterial blood pressure reduction. It is rich in fruits, vegetables, whole grains, and low-fat dairy foods; includes meat, fish, poultry, nuts, and beans; and is limited in sugar-sweetened foods and beverages, red meat, and added fats. Dietary counseling will be provided during each of 7 control visits within the 12-month time of observation.</description>
    <arm_group_label>Dietary And Lifestyle Counseling</arm_group_label>
    <other_name>DASH diet implementation with lifestyle changes support</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Optimal Medical Treatment</intervention_name>
    <description>Optimal Medical Treatment as per 2013 ESC Guidelines on the Management of Stable Coronary Artery Disease.</description>
    <arm_group_label>Dietary And Lifestyle Counseling</arm_group_label>
    <arm_group_label>Optimal Medical Treatment</arm_group_label>
    <other_name>OMT</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  coronary atheroslerotic lesions confirmed in the screening CCTA with reduction of the&#xD;
             artery diameter less than 70% in 2 or more coronary artery segments&#xD;
&#xD;
          -  no indications for coronary angiography / revascularization (no documented significant&#xD;
             ischemia of myocardium)&#xD;
&#xD;
          -  free and informed consent of the person concerned&#xD;
&#xD;
          -  willingness to follow the strict directions given by the investigators&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  any valvular heart disease requiring cardiac surgery (or expected cardiac surgery&#xD;
             intervention within 12 moths)&#xD;
&#xD;
          -  diagnosis of dilated / hypertrophic cardiomyopathy&#xD;
&#xD;
          -  diagnosis of DM t. 2&#xD;
&#xD;
          -  past CABG procedure&#xD;
&#xD;
          -  women in reproductive age&#xD;
&#xD;
          -  known genetic factors with a possible impact on the progres of coronary&#xD;
             atherosclerotic lesions (e. i. congenital metabolic disorders, familial&#xD;
             hyperlipidemias)&#xD;
&#xD;
          -  low quality of the CCTA data&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jan Henzel, MD</last_name>
    <role>Study Director</role>
    <affiliation>Institute of Cardiology, Warsaw, Poland</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jan Henzel, MD</last_name>
    <phone>+48600599211</phone>
    <email>jhenzel@ikard.pl</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Cezary KÄ™pka, Asst. Prof.</last_name>
    <phone>+48725993883</phone>
    <email>ckepka@ikard.pl</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Institute of Cardiology</name>
      <address>
        <city>Warsaw</city>
        <zip>04-628</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jan Henzel, MD</last_name>
      <phone>+48223434342</phone>
      <email>jhenzel@ikard.pl</email>
    </contact>
    <contact_backup>
      <last_name>Cezary Kepka, prof.</last_name>
      <phone>+48223434342</phone>
      <email>ckepka@ikard.pl</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Poland</country>
  </location_countries>
  <verification_date>November 2015</verification_date>
  <study_first_submitted>October 7, 2015</study_first_submitted>
  <study_first_submitted_qc>October 7, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 8, 2015</study_first_posted>
  <last_update_submitted>November 13, 2015</last_update_submitted>
  <last_update_submitted_qc>November 13, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 16, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Institute of Cardiology, Warsaw, Poland</investigator_affiliation>
    <investigator_full_name>Cezary Kepka</investigator_full_name>
    <investigator_title>Ass. Prof.</investigator_title>
  </responsible_party>
  <keyword>coronary artery disease</keyword>
  <keyword>atherosclerosis</keyword>
  <keyword>DASH diet</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Atherosclerosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

